Pharmacological targeting of actin-dependent dynamin oligomerization ameliorates chronic kidney disease in diverse animal models.
about
PodocytesPodocyte endocytosis in the regulation of the glomerular filtration barrierThe FERM protein EPB41L5 regulates actomyosin contractility and focal adhesion formation to maintain the kidney filtration barrier.Alteration of histone H3K4 methylation in glomerular podocytes associated with proteinuria in patients with membranous nephropathy.Drug discovery in focal and segmental glomerulosclerosisNovel therapeutic approaches for chronic kidney disease due to glomerular disorders.Dissecting the genetic components of a quantitative trait locus for blood pressure and renal pathology on rat chromosome 3.Unwinding focal segmental glomerulosclerosisProtein kinase C ϵ stabilizes β-catenin and regulates its subcellular localization in podocytes.Targeting the podocyte cytoskeleton: from pathogenesis to therapy in proteinuric kidney disease.The next generation of therapeutics for chronic kidney diseasePodocyte-actin dynamics in health and disease.Podocytes from the diagnostic and therapeutic point of view.Optimal management of primary focal segmental glomerulosclerosis in adultsRecent Treatment Advances and New Trials in Adult Nephrotic Syndrome.HIV infection is influenced by dynamin at 3 independent points in the viral life cycle.Ultrastructural Characterization of the Glomerulopathy in Alport Mice by Helium Ion Scanning Microscopy (HIM).Drugs targeting dynamin can restore cytoskeleton and focal contact alterations of urinary podocytes derived from patients with nephrotic syndrome.Networks that link cytoskeletal regulators and diaphragm proteins underpin filtration function in Drosophila nephrocytes.The Evolving Complexity of the Podocyte Cytoskeleton.O-linked β-N-acetylglucosamine modification of proteins is essential for foot process maturation and survival in podocytes.Dynamin Autonomously Regulates Podocyte Focal Adhesion Maturation.Actin dynamics at focal adhesions: a common endpoint and putative therapeutic target for proteinuric kidney diseases.A vital role for myosin-9 in puromycin aminonucleoside-induced podocyte injury by affecting actin cytoskeleton.Molecular Mechanisms of Proteinuria in Focal Segmental Glomerulosclerosis.Nephrin Signaling in the Podocyte: An Updated View of Signal Regulation at the Slit Diaphragm and Beyond.Polymer Nanoparticle Engineering for Podocyte Repair: From in Vitro Models to New Nanotherapeutics in Kidney Diseases.Understanding Podocyte Biology to Develop Novel Kidney TherapeuticsPlectin protects podocytes from adriamycin-induced apoptosis and F-actin cytoskeletal disruption through the integrin α6β4/FAK/p38 MAPK pathway
P2860
Q26766118-519F730B-1E95-4B00-AC45-4813BF0002D4Q27004073-D9DCE98B-DB60-404B-95D9-9F01D4B37DFBQ33790864-ED3A8233-086B-44A8-8237-BF7B3A416FC5Q36195369-CFE8389E-A387-47DC-A111-92922937122DQ36924116-EEAD7CCD-36CD-419F-96ED-C480E19D0CC7Q37139492-34160D75-C2A8-476A-AF2A-9E111B19CB37Q37558426-F4D8D5E0-FA36-451F-B846-762A41363ED5Q38685434-EFF6D644-D973-4800-A65F-46F7D7E71771Q38702391-F00E70EF-DE4E-4CDA-94ED-28D7F7F0C824Q38770231-1A8BFCF2-895B-4233-8D30-3723B3474F37Q38845590-35E2B603-DF26-4643-96EA-D48BE6D72D5CQ38940494-7F51672A-6142-4ABF-8A90-48E9960491FCQ39309473-4E90BB83-9DA5-4D1A-870E-D2D5E7D590A3Q39331611-966E9407-64E0-4923-90A0-ED1E816B7303Q39335899-0B882322-3219-475C-9F2E-EF06A41C2A9DQ40283606-4D77698E-9BFE-4466-A851-C1FD7FCCDC1FQ41718435-62FDFA16-B69B-4041-B014-F6A478BACDA8Q42226446-7EAC8307-E310-491F-B446-D4CB68DA159BQ49846333-5E5B19E8-A3C0-459E-95EC-58D8E5E29C97Q50231801-AF2E62D6-383C-44D9-9AEA-4FA543677E99Q51087880-E62380E9-F2B5-43A3-8278-A6708D62C522Q51631984-B24A3221-B09A-40FC-837C-DE3F031D8AD2Q52573827-516AB688-04F8-43A2-BE93-B065C38785A2Q52668598-E2BC3ECA-5D4A-4D07-9A6E-36A5091982C0Q52715295-E8AAC46B-D98D-43E2-87D3-EE46D73390FBQ55376726-3F7B56CC-69D3-4032-AEDC-047957C04C11Q55715653-D552DAD5-36B5-4D5A-8941-C099F954361FQ57175033-FFEE04AE-4A74-406F-898D-5F8EE245D84DQ58760505-EFBCF5FB-CA6E-43B4-953D-C0F6CDE608AD
P2860
Pharmacological targeting of actin-dependent dynamin oligomerization ameliorates chronic kidney disease in diverse animal models.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Pharmacological targeting of a ...... ease in diverse animal models.
@ast
Pharmacological targeting of a ...... ease in diverse animal models.
@en
type
label
Pharmacological targeting of a ...... ease in diverse animal models.
@ast
Pharmacological targeting of a ...... ease in diverse animal models.
@en
prefLabel
Pharmacological targeting of a ...... ease in diverse animal models.
@ast
Pharmacological targeting of a ...... ease in diverse animal models.
@en
P2093
P2860
P50
P356
P1433
P1476
Pharmacological targeting of a ...... ease in diverse animal models.
@en
P2093
Aleksandr Vasilyev
Beina Teng
Changkyu Gu
Changli Wei
Chuang Chen
Faikah Gueler
Irini Tossidou
Jochen Reiser
Joon-Keun Park
Lynne Staggs
P2860
P2888
P304
P356
10.1038/NM.3843
P407
P577
2015-05-11T00:00:00Z